menu
Main Data: 31/12 Year 2005 | |
Consolidated statement of income (international practice in accordance with IAS/IFRS) | Millions/Euro |
– total revenues | 398.79 |
– gross margin | 156.39 |
– total operating cost | 117.33 |
– net operating profit | 35.58 |
– financial expenses, net | 7.54 |
– net income before taxes | 12.46 |
Consolidated balance sheet | Millions/Euro |
– operating capital | 77.40 |
– fixed assets, net | 133.57 |
– reserves and MLT non financial payables | -29.07 |
– net financial position | -86.84 |
– stockholders’ equity | 95.06 |
Other information | Millions/Euro |
– depreciation | 13.61 |
– R & D expenses | 18.27 |
Euro | |
Dividend per share | 0.40 |
No. | |
Employees | 2,686 |
Euro | |
Shares outstanding | 18,772,000 |
Main Data: 30/06 Year 2005 | |
Consolidated statement of income (international practice in accordance with IAS/IFRS) | Millions/Euro |
– total revenues | 156.5 |
– gross margin | 58.9 |
– total operating cost | 57.6 |
– net operating profit | 1.3 |
– financial expenses, net | 3.2 |
– net income before taxes | -1.1 |
Consolidated balance sheet | Millions/Euro |
– operating capital | 82.6 |
– fixed assets, net | 132.0 |
– reserves and MLT non financial payables | -30.5 |
– net financial position | -101.8 |
– stockholders’ equity | 82.3 |
Other information | Millions/Euro |
– depreciation | 5.2 |
– R & D expenses | 9.3 |
No. | |
Employees | 2,617 |
Euro | |
Shares outstanding | 18,772,000 |
Net sales by sector: Year 2005 | ||
Millions/Euro | ||
tea, herbs & coffee | 70.88 | 17.77% |
pharmaceuticals packaging | 223.43 | 56.03% |
pharmaceuticals processing | 104.48 | 26.20% |
Total | 398.79 | 100.00% |
Net Sales by Country: Year 2005 | ||
Millions/Euro | ||
E.U. (excluding Italy) | 156.51 | 39.25% |
Other European countries | 31.38 | 7.87% |
North America | 86.25 | 21.63% |
Asia & Middle East | 50.28 | 12.61% |
Other countries | 35.77 | 8.97% |
Total exports | 360.19 | 90.32% |
Italy | 38.60 | 9.68% |
Total | 398.79 | 100.00% |